Sedana Medical AB (ST:SEDANA) — Market Cap & Net Worth
Market Cap & Net Worth: Sedana Medical AB (SEDANA)
Sedana Medical AB (ST:SEDANA) has a market capitalization of $91.40 Million (Skr849.33 Million) as of June 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #19638 globally and #343 in its home market, demonstrating a -1.16% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sedana Medical AB's stock price Skr8.55 by its total outstanding shares 99336960 (99.34 Million). Review SEDANA liabilities breakdown to assess the company's total debt and financial obligations.
Sedana Medical AB Market Cap History: 2017 to 2026
Sedana Medical AB's market capitalization history from 2017 to 2026. Data shows growth from $101.56 Million to $91.40 Million (4.11% CAGR).
Sedana Medical AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sedana Medical AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.55x
Sedana Medical AB's market cap is 0.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $101.56 Million | $40.43 Million | -$3.88 Million | 2.51x | N/A |
| 2018 | $207.93 Million | $57.90 Million | -$6.87 Million | 3.59x | N/A |
| 2019 | $362.93 Million | $71.65 Million | -$16.36 Million | 5.07x | N/A |
| 2020 | $916.69 Million | $141.77 Million | -$27.14 Million | 6.47x | N/A |
| 2021 | $1.05 Billion | $159.15 Million | -$57.97 Million | 6.59x | N/A |
| 2022 | $199.91 Million | $122.86 Million | -$73.51 Million | 1.63x | N/A |
| 2023 | $247.59 Million | $153.87 Million | -$59.61 Million | 1.61x | N/A |
| 2024 | $203.97 Million | $178.75 Million | -$10.67 Million | 1.14x | N/A |
| 2025 | $109.90 Million | $200.23 Million | -$59.24 Million | 0.55x | N/A |
Competitor Companies of SEDANA by Market Capitalization
Companies near Sedana Medical AB in the global market cap rankings as of June 18, 2026.
Key companies related to Sedana Medical AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Sedana Medical AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Sedana Medical AB's market cap moved from $101.56 Million to $ 91.40 Million, with a yearly change of 4.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr91.40 Million | -16.83% |
| 2025 | Skr109.90 Million | -46.12% |
| 2024 | Skr203.97 Million | -17.62% |
| 2023 | Skr247.59 Million | +23.85% |
| 2022 | Skr199.91 Million | -80.93% |
| 2021 | Skr1.05 Billion | +14.34% |
| 2020 | Skr916.69 Million | +152.58% |
| 2019 | Skr362.93 Million | +74.55% |
| 2018 | Skr207.93 Million | +104.74% |
| 2017 | Skr101.56 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Sedana Medical AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $91.40 Million USD |
| MoneyControl | $91.40 Million USD |
| MarketWatch | $91.40 Million USD |
| marketcap.company | $91.40 Million USD |
| Reuters | $91.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more